References
- Xing, J., Watkins, W. S., Shlien, A., Walker, E., Huff, C. D., Witherspoon, D. J., Zhang, Y., Simonson, T. S., Weiss, R. B., Schiffman, J. D., Malkin, D., Woodward, S. R. and Jorde, L. B. (2010) Toward a more uniform sampling of human genetic diversity: a survey of worldwide populations by high-density genotyping. Genomics, (in press).
- Ku, C. S., Loy, E. Y., Salim, A., Pawitan, Y. and Chia, K. S. (2010) The discovery of human genetic variations and their use as disease markers: past, present and future. J. Hum. Genet. 55, 403-415. https://doi.org/10.1038/jhg.2010.55
- Manolio, T. A., Brooks, L. D. and Collins, F. S. (2008) A HapMap harvest of insights into the genetics of common disease. J. Clin. Invest. 118, 1590-1605. https://doi.org/10.1172/JCI34772
- Abrahams, E., Ginsburg, G. S. and Silver, M. (2005) The personalized medicine coalition: goals and strategies. Am. J. Pharmacogenomics 5, 345-355. https://doi.org/10.2165/00129785-200505060-00002
- Heikes, K. E., Eddy, D. M., Arondekar, B. and Schlessinger, L. (2008) Diabetes risk calculator: a simple tool for detecting undiagnosed diabetes and pre-diabetes. Diabetes Care 31, 1040-1045. https://doi.org/10.2337/dc07-1150
- Liu, J., Wyatt, J. C. and Altman, D. G. (2006) Decision tools in healthcare: focus on the problem, not the solution. BMC Med. Inform. Decis. Mak. 6, 4. https://doi.org/10.1186/1472-6947-6-4
- Hariri, S., Yoon, P. W., Moonesinghe, R., Valdez, R. and Khoury, M. J. (2006) Evaluation of family history as a risk factor and screening tool for detecting undiagnosed diabetes in a nationally representative survey population. Genet. Med. 8, 752-759. https://doi.org/10.1097/01.gim.0000250205.73963.f3
- Feero, W. G., Bigley, M. B. and Brinner, K. M. (2008) New standards and enhanced utility for family health history information in the electronic health record: an update from the American Health Information Community's Family Health History Multi-Stakeholder Workgroup. J. Am. Med. Inform. Assoc. 15, 723-728. https://doi.org/10.1197/jamia.M2793
- Willard, H. (2009) Organization, variation, and expression of the human genome as a foundation of genomic and personalized medicine; in Genomics and personalized medicine. Willard, H., and Ginsburg, G. S. (eds.), pp. 4-22, Elsevier, San Diego, CA.
- Hawkins, R. D., Hon, G. C. and Ren, B. (2010) Next-generation genomics: an integrative approach. Nat. Rev. Genet. 11, 476-486. https://doi.org/10.1038/nrg2795
- Carenini, M. (2009) ReMINE: an ontology-based risk management platform. Stud. Health Technol. Inform. 148, 32-42.
- Huang, E. and Huang, A. (2009) Breast cancer and genomic medicine; in Genomics and personalized medicine, Willard, H., and Ginsburg, G. S. (eds.), pp. 869-878, Elsevier, San Diego, CA.
- Wiesner, G., Slavin, T. and Barnholtz-Sloan, J. (2009) Colorectal cancer; in Genomics and personalized medicine, Willard, H., and Ginsburg, G. S. (eds.), pp. 879-897, Elsevier, San Diego, CA.
- Dave, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P., Boerma, E. J., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., Muller-Hermelink, H. K., Gascoyne, R. D., Delabie, J., Rimsza, L. M., Braziel, R. M., Grogan, T. M., Campo, E., Jaffe, E. S., Dave, B. J., Sanger, W., Bast, M., Vose, J. M., Armitage, J. O., Connors, J. M., Smeland, E. B., Kvaloy, S., Holte, H., Fisher, R. I., Miller, T. P., Montserrat, E., Wilson, W. H., Bahl, M., Zhao, H., Yang, L., Powell, J., Simon, R., Chan, W. C. and Staudt, L. M. (2006) Molecular diagnosis of Burkitt's lymphoma. N. Engl. J. Med. 354, 2431-2442. https://doi.org/10.1056/NEJMoa055759
- Voora, D., McLeod, H. L., Eby, C. and Gage, B. F. (2005) The pharmacogenetics of coumarin therapy. Pharmacogenomics 6, 503-513. https://doi.org/10.2217/14622416.6.5.503
- Ross, J. S., Schenkein, D. P., Pietrusko, R., Rolfe, M., Linette, G. P., Stec, J., Stagliano, N. E., Ginsburg, G. S., Symmans, W. F., Pusztai, L. and Hortobagyi, G. N. (2004) Targeted therapies for cancer 2004. Am. J. Clin. Pathol. 122, 598-609. https://doi.org/10.1309/5CWPU41AFR1VYM3F
- Metzker, M. L. (2010) Sequencing technologies - the next generation. Nat. Rev. Genet. 11, 31-46. https://doi.org/10.1038/nrg2626
- Service, R. F. (2006) Gene sequencing. The race for the $1,000 genome. Science 311, 1544-1546. https://doi.org/10.1126/science.311.5767.1544
- Hunter, D. J., Khoury, M. J. and Drazen, J. M. (2008) Letting the genome out of the bottle--will we get our wish? N. Engl. J. Med. 358, 105-107. https://doi.org/10.1056/NEJMp0708162
- Clifton, J. M., VanBeuge, S. S., Mladenka, C. and Wosnik, K. K. (2010) The Genetic Information Nondiscrimination Act 2008: what clinicians should understand. J. Am. Acad. Nurse Pract. 22, 246-249. https://doi.org/10.1111/j.1745-7599.2010.00504.x
- Vastag, B. (2006) New clinical trials policy at FDA. Nat. Biotechnol. 24, 1043. https://doi.org/10.1038/nbt0906-1043
- Botkin, J. R., Teutsch, S. M., Kaye, C. I., Hayes, M., Haddow, J. E., Bradley, L. A., Szegda, K. and Dotson, W. D. (2010) Outcomes of interest in evidence-based evaluations of genetic tests. Genet. Med. 12, 228-235. https://doi.org/10.1097/GIM.0b013e3181cdde04
- Batchelder, K. and Miller, P. (2006) A change in the market--investing in diagnostics. Nat. Biotechnol. 24, 922-926. https://doi.org/10.1038/nbt0806-922
- Ginsburg, G. S. and Willard, H. F. (2009) Genomic and personalized medicine: foundations and applications. Transl. Res. 154, 277-287. https://doi.org/10.1016/j.trsl.2009.09.005
Cited by
- Towards a personalized risk assessment for exposure of humans to toxic substances vol.24, pp.2, 2016, https://doi.org/10.1590/1414-462X201600020135
- Future perspectives of personalized medicine in traditional Chinese medicine: A systems biology approach vol.20, pp.1-2, 2012, https://doi.org/10.1016/j.ctim.2011.10.007
- Sequencing and analysis of a South Asian-Indian personal genome vol.13, pp.1, 2012, https://doi.org/10.1186/1471-2164-13-440
- Acute lung injury and acute respiratory distress syndrome: a genomic perspective vol.35, pp.6, 2011, https://doi.org/10.1016/j.medine.2011.02.003
- State-of-the-Art Technologies to Interrogate Genetic/Genomic Components of Drug Response vol.1, pp.3, 2013, https://doi.org/10.1007/s40142-013-0022-6
- Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects vol.23, pp.4, 2017, https://doi.org/10.1007/s11948-016-9828-4
- Lesión pulmonar aguda y síndrome de distrés respiratorio agudo: una perspectiva genómica vol.35, pp.6, 2011, https://doi.org/10.1016/j.medin.2011.02.002
- Genetic testing: predictive value of genotyping for diagnosis and management of disease vol.2, pp.2, 2011, https://doi.org/10.1007/s13167-011-0077-y
- Progress in unraveling the genetic etiology of Parkinson disease in a genomic era vol.31, pp.3, 2015, https://doi.org/10.1016/j.tig.2015.01.004
- Personalized medicine: a patient - centered paradigm vol.9, pp.1, 2011, https://doi.org/10.1186/1479-5876-9-206
- Downsizing genomic medicine: Approaching the ethical complexity of whole-genome sequencing by starting small vol.13, pp.3, 2011, https://doi.org/10.1097/GIM.0b013e31820f603f
- Design and implementation of the canadian kidney disease cohort study (CKDCS): A prospective observational study of incident hemodialysis patients vol.12, pp.1, 2011, https://doi.org/10.1186/1471-2369-12-10
- Whole-genome and whole-exome sequencing in neurological diseases vol.8, pp.9, 2012, https://doi.org/10.1038/nrneurol.2012.148
- A Quantitative Analysis of the Mass Media Coverage of Genomics Medicine in China: A Call for Science Journalism in the Developing World vol.18, pp.4, 2014, https://doi.org/10.1089/omi.2013.0108
- Advancing Global Precision Medicine: An Overview of Genomic Testing and Counseling Services in Malaysia vol.21, pp.12, 2017, https://doi.org/10.1089/omi.2017.0136